AI-Driven and Cybersecurity Integration in Pharmaceutical ColdChain Operation
IFR Journal of Biochemistry and Biomedical Science · 12.10.2025 · 1 (2) · 8-12
DOI: 10.70146/bbsv01i02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift IFR Journal of Biochemistry and Biomedical Science, erschienen am 12.10.2025. Verfasst von Sunia Sattar Khan.
Abstract (Originalsprache)
The global pharmaceutical cold chain is currently undergoing a rapid digital transformation, shiftingfrom traditional reactive logistics to a predictive, intelligence-driven ecosystem designed to secure vaccineintegrity. This report explores the critical convergence of Artificial Intelligence (AI), the Internet of Things(IoT), and cybersecurity in mitigating disruption risks within vaccine supply chains. Historically, vaccinewastage due to temperature excursions has reached up to 30%; however, the implementation of AIoTarchitectures utilizing deep learning models such as convolutional autoencoders now enables real-time anomalydetection with over 90% accuracy (Frontiers, 2024; MDPI, 2025). While digitalization enhances visibility, it simultaneously introduces "digital fragility," expanding the attacksurface for cyber adversaries targeting critical healthcare infrastructure (PMC/NCBI, 2025). To address thesevulnerabilities, this study examines the integration of Blockchain technology as an immutable ledger to ensuredata integrity and end-to-end traceability, creating a "trust layer" for international distribution (ScienceDirect, 2024; IEEE, 2024). Furthermore, the transition toward Edge AI and Zero-Trust architectures is highlightedas aprimary defense mechanism for global distribution hubs, ensuring operational resilience even in regions withinconsistent connectivity (Fortinet, 2024). The report concludes with a look toward future trends, including the necessity of quantum-resistant cryptography and the role of Generative AI in simulating "black swan" disruptions. By aligning technological deployment with evolving regulatory frameworks like the Drug Supply Chain Security Act (DSCSA), thepharmaceutical industry can establish a secure, sustainable, and highly resilient cold chain capable of safeguarding global public health (ResearchGate, 2025).
Zitieren
APA
Khan, S. S. (2025). AI-Driven and Cybersecurity Integration in Pharmaceutical ColdChain Operation. IFR Journal of Biochemistry and Biomedical Science, 1(2), 8-12. https://doi.org/10.70146/bbsv01i02.002
Vancouver
Khan SS. AI-Driven and Cybersecurity Integration in Pharmaceutical ColdChain Operation. IFR Journal of Biochemistry and Biomedical Science. 2025;1(2):8-12. doi:10.70146/bbsv01i02.002
BibTeX
@article{Khan2025,
author = {Khan, Sunia Sattar},
title = {AI-Driven and Cybersecurity Integration in Pharmaceutical ColdChain Operation},
journal = {IFR Journal of Biochemistry and Biomedical Science},
year = {2025},
volume = {1},
number = {2},
pages = {8--12},
doi = {10.70146/bbsv01i02.002}
}
EUVIMED